Literature DB >> 12797627

Angiotensin AT1/AT2 receptors: regulation, signalling and function.

Elena Kaschina1, Thomas Unger.   

Abstract

Angiotensin II (Ang II), the biologically active component of renin-angiotensin system (RAS), acts through two receptor subtypes, the AT1 and the AT2 receptor. All classic physiological effects of Ang II, such as vasoconstriction, aldosterone and vasopressin release, sodium and water retention and sympathetic facilitation, are mediated by the AT1 receptor. Ang II, via its AT1 receptor, is also involved in cell proliferation, left ventricular hypertrophy, nephrosclerosis, vascular media hypertrophy, endothelial dysfunction, neointima formation and processes leading to athero-thrombosis. Recent investigations have established a role for the AT2 receptor in cardiovascular, brain and renal function as well as in the modulation of various biological processes involved in development, cell differentiation, tissue repair and apoptosis. This review summarizes new insights in the regulation, signalling and (patho-) physiological functions of AT1 and AT2 receptors. An extensive review on angiotensin receptors has been published recently (de Gasparo M et al., Pharmacol Rev 2000; 52: 415-72).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12797627     DOI: 10.1080/08037050310001057

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  116 in total

1.  Expression of astrocytic type 2 angiotensin receptor in central nervous system inflammation correlates with blood-brain barrier breakdown.

Authors:  Laila Füchtbauer; Henrik Toft-Hansen; Reza Khorooshi; Trevor Owens
Journal:  J Mol Neurosci       Date:  2010-04-23       Impact factor: 3.444

2.  Oxidative stress alters renal D1 and AT1 receptor functions and increases blood pressure in old rats.

Authors:  Gaurav Chugh; Mustafa F Lokhandwala; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-13

3.  Garlic (Allium sativum) down-regulates the expression of angiotensin II AT(1) receptor in adrenal and renal tissues of streptozotocin-induced diabetic rats.

Authors:  Mohamed H Mansour; Khaled Al-Qattan; Martha Thomson; Muslim Ali
Journal:  Inflammopharmacology       Date:  2012-05-30       Impact factor: 4.473

Review 4.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 5.  Modulation of glomerulosclerosis.

Authors:  Li-Jun Ma; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

6.  Simultaneous analysis of angiotensin peptides by LC-MS and LC-MS/MS: metabolism by bovine adrenal endothelial cells.

Authors:  Lijie Cui; Kasem Nithipatikom; William B Campbell
Journal:  Anal Biochem       Date:  2007-07-05       Impact factor: 3.365

7.  Polymorphisms in the renin-angiotensin system and migraine in women.

Authors:  Markus Schürks; Robert Y L Zee; Julie E Buring; Tobias Kurth
Journal:  Headache       Date:  2008-10-27       Impact factor: 5.887

Review 8.  Obstructive nephropathy: insights from genetically engineered animals.

Authors:  Jean-Loup Bascands; Joost P Schanstra
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

9.  Angiotensin II and III metabolism and effects on steroid production in the HAC15 human adrenocortical cell line.

Authors:  Kenji Oki; Phillip G Kopf; William B Campbell; Milay Luis Lam; Takeshi Yamazaki; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez
Journal:  Endocrinology       Date:  2012-12-07       Impact factor: 4.736

Review 10.  Are angiotensin receptor blockers neuroprotective?

Authors:  Christa Thöne-Reineke; Mathias Zimmermann; Christian Neumann; Maxim Krikov; Jun Li; Nadja Gerova; Thomas Unger
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.